BDBM593050 2-(4-((4-((2-azaspiro[3.3]heptan-6- yl)methoxy)-5-chloropyrimidin-2- yl)amino)-3-methyl-1H-pyrazol-1- yl)-2-methylpropanenitrile::US11578061, Example 28
SMILES Cc1nn(cc1Nc1ncc(Cl)c(OCC2CC3(CNC3)C2)n1)C(C)(C)C#N
InChI Key InChIKey=REJNOOUBBUWCAM-UHFFFAOYSA-N
Data 1 IC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 1 hit for monomerid = 593050
TargetLeucine-rich repeat serine/threonine-protein kinase 2 [970-2527](Human)
Halia Therapeutics
US Patent
Halia Therapeutics
US Patent
Affinity DataIC50: <50nMAssay Description:LRRKtide substrate (peptide sequence RLGRDKYKTLRQIRQ, derived from human ezrin [amino acids 561-573], moesin [amino acids 539-553] and radixin [amino...More data for this Ligand-Target Pair